Antimicrobials effective for inhibition of enterohaemorrhagic Escherichia coli strains O26, O111, and O157 and their effects on Shiga toxin releases.
The susceptibilities of major enterohaemorrhagic Escherichia coli (EHEC) strains to antimicrobial agents and the cytotoxicity of these agents were examined using a total of 38 strains of E. coli O26, O111, and O157, which are the major serogroups of EHEC. Among the 38 strains, 35, 36, and 36 were susceptible to amikacin, imipenem and norfloxacin, respectively. These antimicrobial agents were further examined to determine their cytotoxicity on Vero cells as well as their effect on the release of Shiga toxins along with trimethoprim/sulfamethoxazole. Each of the E. coli O26, O111, and O157 strains containing both stx1 and stx2 genes were grown in the absence or presence of these agents at 1/4 minimal inhibitory concentration for 6 h, 12 h, and 18 h. At the concentrations used in this study, none of the agents significantly altered cell count compared with the control group. The level of cytotoxicity in the imipenem group was lower at 12 h and 18 h than their respective controls. In contrast, the level of cytotoxicity in cultures treated with trimethoprim/sulfamethoxazole, norfloxacin and amikacin was increased. The strains were also examined for the release of Shiga toxin 1 and 2 following treatment with the agents, which were measured by the reversed passive latex agglutination method (RPLA). RPLA assay showed a suppression of release of Shiga toxin 2 in the strain cultures containing imipenem. These results indicate that imipenem may be a safe and effective agent for inhibition of these bacteria, which has clinical implications for the treatment of EHEC infections.
Lee
John Hwa
JH
Veterinary Public Health, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University, Jeonju 561-756, Korea. johnhlee@chonbuk.ac.kr
Stein
Barry D
BD
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology*; D002522:Chlorocebus aethiops; D054324:Enterohemorrhagic Escherichia coli / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D004927:Escherichia coli Infections / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D022621:Shiga Toxin / Q000235:genetics / Q000378:metabolism*; D014709:Vero Cells
D000890:Anti-Infective Agents; D022621:Shiga Toxin